TradingView’s own chart and price feed. The page’s numbers are end-of-day closes.
Data provided by Databento (end of day). Next close = the first close after a story against the close before it; official daily closes only, not a call, not advice.
The numbers
fiscal 2025, as filed with the SEC · 66-metric EOD snapshot via Databento
Market cap$9M
Enterprise value$3.1M
Revenue$155,000 +453.6%
True FCF (ex-SBC)$-11.0M −28.6%
Rule of 40-6532.2%
Operating margin-7504.5%
True FCF Yield-119.5%
EPS, diluted$89.61 −97.7%
Modern Valuation (EOD)
Market Cap$9M
Enterprise Value$3.1M
EV / True FCF—
EV / FCF—
EV / Gross Profit—
EV / EBIT—
EV / Sales20.00
P / E (GAAP)—
P / FCF—
P / Oper. CF—
P / Book3.52
Owner & Cash Yields
True FCF Yield-119.5%
FCF Yield-118.0%
Owner Earn. Yield-131.2%
Earnings Yield-129.8%
Shareholder Yield—
Buyback Yield—
Dividend Yield—
Dividend / sh—
Payout Ratio—
FCF / sh$-16.67
EPS (diluted)$89.61
Compounder & Returns
Rule of 40-6532.2%
ROIC—
Cash ROIC (CROIC)—
GP / Assets—
ROE-457.6%
ROA-165.1%
Gross Margin—
Oper. Margin-7504.5%
Net Margin-7685.2%
FCF Margin-6985.8%
True FCF Margin-7072.3%
Quality & Dilution
Cash Conversion—
Accrual Ratio−15.1%
SBC % of FCF—
SBC % of Rev86.5%
Reinvest. Rate—
Sales Growth Y/Y+453.6%
Sales 3Y CAGR—
EPS Growth Y/Y−97.7%
FCF Growth Y/Y−28.6%
FCF 3Y CAGR—
Share Change Y/Y+3098.2%
Balance Sheet & Scale
Revenue (FY)$155,000
Gross Profit (FY)—
Oper. Income (FY)$-11.6M
GAAP Net Income$-11.9M
True FCF (ex-SBC)$-11.0M
Cash & Equiv$6.1M
Total Debt—
Net Cash (Debt)$6.1M
Net Cash % MCap+66.2%
Debt / FCF (yrs)—
Current Ratio2.41649,528 sh
Price & Technicals (EOD)
Perf Week−55.42%
Perf Month+836.28%
Perf Quarter+260.90%
Perf Half Y+171.80%
Perf YTD+127.49%
SMA 20 Dist+94.18%$0.74
SMA 50 Dist+210.14%$0.46
SMA 100 Dist+44.78%$0.99
Window High−71.17%$5.00
Window Low+1222.31%$0.11
RSI (14) · Vol58.31235%v
Income Distribution & Cash Flow ConversionHow every dollar of SLXN revenue flows through cost of goods, operating expenses, taxes, GAAP net income, and dilution-adjusted free cash flow
Standard Free Cash Flow (FCF)$-10.8M(-6985.8% margin)
Less: Stock-Based Comp (SBC)−$134,000
True FCF (Owner Cash ex-SBC)$-11.0M(-7072.3% of rev)
Revenue by fiscal year
$153,000FY23
$28,000FY24
$155,000FY25
Operating leverage — margins
GrossOperatingNet
Unlocked SEC EDGAR Accounting Statements (USD)All 3 statements · Common-size (% of Revenue / Assets) · YoY growth · Tap any core row to explain
Line Item (USD)
FY2023
FY2024
FY2025
YoY Δ
CAGR
Trend
Income Statement
Revenue ▸
$153,000
$28,000
$155,000
+453.6%
+0.7%
Research & Development (R&D)
$3.7M
$5.8M
$7.1M
+22.8%
+38.8%
Total Operating Expenses
$4.7M
$12.6M
$11.6M
−7.5%
+57.6%
Operating Income (EBIT) ▸
$-4.7M
$-12.6M
$-11.6M
+7.5%
—
Income Tax Expense
$32,000
$10,000
$3,000
−70.0%
−69.4%
GAAP Net Income ▸
$-5.1M
$-16.5M
$-11.9M
+27.9%
—
Diluted EPS ▸
$659.55
$3955.11
$89.61
−97.7%
−63.1%
Diluted Shares
7,493
4,157
132,951
+3098.2%
+321.2%
Balance Sheet
Cash & Equivalents
$4.6M
$1.3M
$6.1M
+378.3%
+14.4%
Total Current Assets
$5.0M
$2.3M
$6.6M
+195.0%
+15.5%
Total Assets
$5.3M
$2.9M
$7.2M
+152.0%
+17.2%
Total Current Liabilities
$2.2M
$3.5M
$2.8M
−21.7%
+12.1%
Total Liabilities
$2.3M
$6.9M
$4.6M
−32.7%
+43.0%
Stockholders' Equity
$3.0M
$-4.0M
$2.6M
+165.3%
−6.9%
Net Cash / (Net Debt)
$4.6M
$1.3M
$6.1M
+378.3%
+14.4%
Invested Capital
$-1.6M
$-5.3M
$-3.5M
+34.0%
—
Cash Flow & Capital Allocation
Operating Cash Flow (OCF) ▸
$-4.5M
$-8.4M
$-10.8M
−28.9%
—
Depreciation & Amortization (D&A)
$45,000
$25,000
$14,000
−44.0%
−44.2%
Stock-Based Compensation (SBC)
$130,000
$5.9M
$134,000
−97.7%
+1.5%
Capital Expenditures (CapEx)
$12,000
$22,000
$9,000
−59.1%
−13.4%
Free Cash Flow (FCF) ▸
$-4.5M
$-8.4M
$-10.8M
−28.6%
—
True FCF (ex-SBC Owner Cash)
$-4.7M
$-14.3M
$-11.0M
+23.2%
—
Fundamentals, income distribution and multi-year statements from SEC EDGAR filings (public domain). Valuation multiples, performance and technicals computed from Databento 1D EOD closes. For information only, not investment advice.
The Wire at 7 AM ET, free. Top stories with a bull and a bear case on each, every morning. No account needed.
What happened · big days
38 big days in a year, and what we hold on each
A big day is a close more than 12.26% from the one before, three times SLXN’s median day (4.09%). On 0 of the 38, its peer group moved the same way at least half as far. We show what we hold. We never name a cause.
every other trading daya big day, numbered in the list below±12.26%Hover a bar for its day. Click a big day to open it.
Shaded: since our stories began, Jun 10. Tap a bar for its day.
#DaySLXNWhat we hold that dayGroup (median of 4) · each
1 Nov 26, 2025+20.42%
Before our storiesgroup +0.7%, did not move with it
1Nov 26, 2025+20.42%
Before our stories
+0.7% did not move with itMRNA +1.1 · AMGN +1.0 · GILD +0.3 · BIIB −0.0
2 Dec 4, 2025+15.16%
Before our storiesgroup −0.4%, did not move with it
2Dec 4, 2025+15.16%
Before our stories
−0.4% did not move with itMRNA +1.2 · BIIB +0.7 · AMGN −1.5 · GILD −1.9
3 Dec 30, 2025−16.79%
Before our storiesgroup −0.8%, did not move with it
3Dec 30, 2025−16.79%
Before our stories
−0.8% did not move with itMRNA −2.4 · GILD −1.4 · AMGN −0.3 · BIIB −0.2
4 Jan 5, 2026+17.02%
Before our storiesgroup −1.9%, did not move with it
4Jan 5, 2026+17.02%
Before our stories
−1.9% did not move with itMRNA +4.2 · BIIB −1.8 · AMGN −2.1 · GILD −2.7
5 Jan 15, 2026+15.09%
Before our storiesgroup −1.4%, did not move with it
5Jan 15, 2026+15.09%
Before our stories
−1.4% did not move with itAMGN +0.3 · BIIB −0.4 · GILD −2.3 · MRNA −3.0
6 Feb 5, 2026−12.72%
Before our storiesgroup +0.2%, did not move with it
6Feb 5, 2026−12.72%
Before our stories
+0.2% did not move with itMRNA −4.4 · BIIB −0.1 · AMGN +0.4 · GILD +2.1
7 Mar 9, 2026+13.29%
Before our storiesgroup +1.9%, did not move with it
7Mar 9, 2026+13.29%
Before our stories
+1.9% did not move with itMRNA +6.1 · AMGN +2.0 · GILD +1.9 · BIIB +1.8
8 Mar 20, 2026−15.21%
Before our storiesgroup −1.5%, did not move with it
8Mar 20, 2026−15.21%
Before our stories
−1.5% did not move with itGILD −2.8 · MRNA −1.9 · BIIB −1.1 · AMGN −0.6
9 Apr 24, 2026−14.90%
Before our storiesgroup −2.1%, did not move with it
9Apr 24, 2026−14.90%
Before our stories
−2.1% did not move with itMRNA −4.0 · GILD −2.4 · BIIB −1.9 · AMGN −1.2
10 Apr 28, 2026−12.75%
Before our storiesgroup +0.5%, did not move with it
10Apr 28, 2026−12.75%
Before our stories
+0.5% did not move with itMRNA −3.2 · AMGN −0.2 · GILD +1.2 · BIIB +1.5
11 May 12, 2026+14.20%
Before our storiesgroup +0.9%, did not move with it
11May 12, 2026+14.20%
Before our stories
+0.9% did not move with itAMGN +2.0 · GILD +1.1 · MRNA +0.7 · BIIB +0.7
12 May 15, 2026−42.06%
Before our storiesgroup −1.9%, did not move with it
12May 15, 2026−42.06%
Before our stories
−1.9% did not move with itAMGN −3.0 · MRNA −2.0 · GILD −1.9 · BIIB +0.8
13 May 20, 2026+96.95%
Before our storiesgroup +0.2%, did not move with it
13May 20, 2026+96.95%
Before our stories
+0.2% did not move with itMRNA +5.3 · AMGN +0.3 · GILD +0.1 · BIIB −1.4
14 May 26, 2026−14.14%
Before our storiesgroup −0.4%, did not move with it
14May 26, 2026−14.14%
Before our stories
−0.4% did not move with itAMGN −1.0 · GILD −0.5 · BIIB −0.3 · MRNA +0.3
15 May 29, 2026+1048.15%
Before our storiesgroup −0.5%, did not move with it
15May 29, 2026+1048.15%
Before our stories
−0.5% did not move with itAMGN +0.1 · BIIB −0.2 · MRNA −0.8 · GILD −1.3
16 Jun 9, 2026−16.52%
Before our storiesgroup −0.0%, did not move with it
16Jun 9, 2026−16.52%
Before our stories
−0.0% did not move with itGILD −2.0 · AMGN −0.3 · MRNA +0.3 · BIIB +3.4
17 Jun 10, 2026−26.62%
Nothing on SLXNgroup −2.8%, did not move with it
17Jun 10, 2026−26.62%
Nothing on SLXNNo SLXN story, brief or results filing in our record that day
−2.8% did not move with itMRNA −3.6 · GILD −3.2 · BIIB −2.4 · AMGN −2.0
18 Jul 29, 2026−34.69%
Nothing on SLXNgroup −1.3%, did not move with it
18Jul 29, 2026−34.69%
Nothing on SLXNNo SLXN story, brief or results filing in our record that day
−1.3% did not move with itMRNA −2.4 · AMGN −1.4 · GILD −1.2 · BIIB +1.8
19 Jul 30, 2026+15.00%
Nothing on SLXNgroup −0.3%, did not move with it
19Jul 30, 2026+15.00%
Nothing on SLXNNo SLXN story, brief or results filing in our record that day
−0.3% did not move with itMRNA +6.3 · AMGN 0.0 · BIIB −0.6 · GILD −1.1
20 Aug 10, 2026−19.79%
Nothing on SLXNgroup +0.5%, did not move with it
20Aug 10, 2026−19.79%
Nothing on SLXNNo SLXN story, brief or results filing in our record that day
+0.5% did not move with itBIIB −0.4 · GILD −0.1 · MRNA +1.1 · AMGN +1.5
21 Aug 11, 2026−31.00%
Nothing on SLXNgroup +0.3%, did not move with it
21Aug 11, 2026−31.00%
Nothing on SLXNNo SLXN story, brief or results filing in our record that day
+0.3% did not move with itBIIB −1.6 · AMGN −0.7 · MRNA +1.3 · GILD +2.0
+1.4% did not move with itGILD +0.1 · AMGN +0.5 · BIIB +2.4 · MRNA +5.1
23 Sep 10, 2026+20.89%
Nothing on SLXNgroup +0.1%, did not move with it
23Sep 10, 2026+20.89%
Nothing on SLXNNo SLXN story, brief or results filing in our record that day
+0.1% did not move with itBIIB +2.2 · MRNA +0.7 · GILD −0.6 · AMGN −2.3
24 Sep 11, 2026−15.43%
Nothing on SLXNgroup +0.0%, did not move with it
24Sep 11, 2026−15.43%
Nothing on SLXNNo SLXN story, brief or results filing in our record that day
+0.0% did not move with itAMGN −1.3 · GILD −0.8 · BIIB +0.8 · MRNA +5.4
25 Sep 18, 2026+14.61%
Nothing on SLXNgroup −1.1%, did not move with it
25Sep 18, 2026+14.61%
Nothing on SLXNNo SLXN story, brief or results filing in our record that day
−1.1% did not move with itAMGN +1.6 · GILD −0.5 · BIIB −1.6 · MRNA −2.5
26 Sep 21, 2026+24.94%
Nothing on SLXNgroup +1.8%, did not move with it
26Sep 21, 2026+24.94%
Nothing on SLXNNo SLXN story, brief or results filing in our record that day
+1.8% did not move with itMRNA +12.3 · AMGN +1.9 · BIIB +1.7 · GILD +0.3
27 Sep 22, 2026−27.90%
Nothing on SLXNgroup +3.6%, did not move with it
27Sep 22, 2026−27.90%
Nothing on SLXNNo SLXN story, brief or results filing in our record that day
+3.6% did not move with itGILD +1.4 · BIIB +2.9 · AMGN +4.3 · MRNA +5.6
28 Sep 23, 2026−19.63%
Nothing on SLXNgroup −0.6%, did not move with it
28Sep 23, 2026−19.63%
Nothing on SLXNNo SLXN story, brief or results filing in our record that day
−0.6% did not move with itAMGN −1.0 · GILD −0.8 · MRNA −0.3 · BIIB +1.0
29 Sep 24, 2026−18.49%
Nothing on SLXNgroup −0.3%, did not move with it
29Sep 24, 2026−18.49%
Nothing on SLXNNo SLXN story, brief or results filing in our record that day
−0.3% did not move with itGILD −1.1 · BIIB −0.5 · AMGN −0.0 · MRNA +7.0
30 Sep 29, 2026+28.18%
Nothing on SLXNgroup +0.4%, did not move with it
30Sep 29, 2026+28.18%
Nothing on SLXNNo SLXN story, brief or results filing in our record that day
+0.4% did not move with itMRNA +3.1 · AMGN +1.3 · GILD −0.6 · BIIB −0.7
31 Sep 30, 2026−12.91%
Nothing on SLXNgroup −1.0%, did not move with it
31Sep 30, 2026−12.91%
Nothing on SLXNNo SLXN story, brief or results filing in our record that day
−1.0% did not move with itMRNA −5.3 · GILD −1.5 · BIIB −0.5 · AMGN −0.5
32 Oct 12, 2026−16.96%
Nothing on SLXNgroup +0.1%, did not move with it
32Oct 12, 2026−16.96%
Nothing on SLXNNo SLXN story, brief or results filing in our record that day
+0.1% did not move with itMRNA −5.0 · GILD −0.5 · AMGN +0.7 · BIIB +1.6
33 Oct 16, 2026−19.05%
Nothing on SLXNgroup −0.9%, did not move with it
33Oct 16, 2026−19.05%
Nothing on SLXNNo SLXN story, brief or results filing in our record that day
−0.9% did not move with itMRNA −7.8 · BIIB −1.1 · GILD −0.8 · AMGN −0.3
34 Oct 23, 2026+14.29%
Nothing on SLXNgroup −1.3%, did not move with it
34Oct 23, 2026+14.29%
Nothing on SLXNNo SLXN story, brief or results filing in our record that day
−1.3% did not move with itGILD −0.7 · BIIB −1.2 · MRNA −1.3 · AMGN −1.8
35 Nov 9, 2026−14.67%
Nothing on SLXNgroup +2.0%, did not move with it
35Nov 9, 2026−14.67%
Nothing on SLXNNo SLXN story, brief or results filing in our record that day
+2.0% did not move with itAMGN +1.0 · GILD +1.5 · BIIB +2.6 · MRNA +5.8
36 Nov 11, 2026+2866.02%
Nothing on SLXNgroup −0.3%, did not move with it
36Nov 11, 2026+2866.02%
Nothing on SLXNNo SLXN story, brief or results filing in our record that day
−0.3% did not move with itAMGN +0.6 · BIIB +0.1 · GILD −0.7 · MRNA −0.8
37 Nov 12, 2026−17.65%
Nothing on SLXNgroup −1.1%, did not move with it
37Nov 12, 2026−17.65%
Nothing on SLXNNo SLXN story, brief or results filing in our record that day
−1.1% did not move with itMRNA −7.0 · BIIB −1.1 · GILD −1.1 · AMGN −0.2
38 Nov 13, 2026−25.56%
Nothing on SLXNgroup −0.1%, did not move with it
38Nov 13, 2026−25.56%
Nothing on SLXNNo SLXN story, brief or results filing in our record that day
−0.1% did not move with itMRNA −3.5 · AMGN −0.3 · GILD +0.1 · BIIB +1.2
A story on the same day is not a cause, and a group move is not proof either. Group: the median of AMGN, GILD, MRNA and BIIB that day, the largest companies in SLXN’s SEC industry; “moved with SLXN” means the same direction and at least half the size.
What’s next · results
Before the next report: what the first day after the last three did
Six trading days after each results filing (SEC 8-K, Item 2.02). SLXN reports before the open, so day 1 is that day’s close. 1 of 3 times, day 6 ended on the same side as day 1.
Reported Nov 12, 2025
day 1+3.56%day 6−12.10%
Reported May 18, 2026
day 1−5.36%day 6+48.55%
Reported Aug 14, 2026
day 1−8.65%day 6−14.33%
Next report: expected mid FebruaryEstimated from the dates of its last four results filings. Not announced. Since the Nov 16 report: −16.67%. Three reports is a small sample.
Each line is SLXN’s close against its close before the filing, on licensed end-of-day closes. What happened after each report, not a forecast; a move on the day is not a cause.
Same industry
SLXN against four biotech peers, a year at 100
SLXN is down 25.3% in a year. Moderna is up 8.7 times, Biogen is up 43.1%, Amgen 35.7% and Gilead Sciences 34.4%. All four did more. Weekly closes, Nov 21, 2025 = 100, on a log scale so a 8.7-fold rise and a 25.3% fall both read honestly.
End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in SLXN’s SEC industry (Biological Products, (No Diagnostic Substances)) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.